Lucy Li, Ph.D., is Executive Director of Corporate Strategy, overseeing the development of the company’s strategy and growth plans. Dr. Li joined BeiGene in 2015 and has served in various leadership roles in Corporate Strategy and Investor Relations, including leadership of the development of BeiGene’s 10-year corporate strategy. Prior to joining BeiGene, Dr. Li was a strategic consultant with Navigant Consulting (now a Guidehouse company) and Campbell Alliance Consulting (now Syneos Health Consulting). During her consulting career, Dr. Li gained a diverse set of experiences across therapeutic and functional areas, including corporate and portfolio strategy, marketing, market access, and finance. Dr. Li received a bachelor’s degree from Peking University and a Ph.D. in neuroscience and neurology from Washington University in St. Louis.